Integer (NYSE:ITGR) Stock Price Expected to Rise, Citigroup Analyst Says

Integer (NYSE:ITGR) had its price target hoisted by equities research analysts at Citigroup from $130.00 to $145.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the medical equipment provider’s stock. Citigroup’s price objective indicates a potential upside of 4.23% from the company’s current price.

Several other analysts also recently issued reports on the company. Truist Financial upped their price objective on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday. Bank of America raised their price objective on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. KeyCorp increased their target price on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Piper Sandler reiterated an “overweight” rating and issued a $140.00 target price (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Finally, Wells Fargo & Company restated an “overweight” rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $145.44.

Integer Trading Down 1.1 %

Shares of ITGR stock opened at $139.11 on Wednesday. The business’s fifty day moving average price is $133.32 and its 200 day moving average price is $125.51. Integer has a 1-year low of $93.52 and a 1-year high of $142.76. The firm has a market capitalization of $4.67 billion, a PE ratio of 42.94, a P/E/G ratio of 2.00 and a beta of 1.12. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same quarter in the prior year, the company posted $1.27 earnings per share. Integer’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, sell-side analysts forecast that Integer will post 5.33 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. TD Private Client Wealth LLC grew its position in shares of Integer by 15.5% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,420 shares of the medical equipment provider’s stock worth $185,000 after acquiring an additional 191 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after acquiring an additional 9,421 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Integer by 3,443.4% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 13,890 shares of the medical equipment provider’s stock worth $1,806,000 after acquiring an additional 13,498 shares in the last quarter. XTX Topco Ltd grew its position in shares of Integer by 31.5% in the 3rd quarter. XTX Topco Ltd now owns 6,764 shares of the medical equipment provider’s stock worth $879,000 after acquiring an additional 1,620 shares in the last quarter. Finally, Jane Street Group LLC grew its position in shares of Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock worth $19,682,000 after acquiring an additional 28,572 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.